Clinical Trial With Riluzole in Spinocerebellar Ataxia Type 2 (ATRIL)

Clinical trial NCT03347344 · COMPLETED

Trial details

NCT number: NCT03347344
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Spinocerebellar Ataxia Type 2

Start date: 2018-01-17
Primary completion: 2020-12-14
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.